APC-Linked Polyclonal Antibody to Myosin Heavy Chain 9, Non Muscle (MYH9)
Cat# MBS2120228-1mL
Size : 1mL
Brand : MyBiosource
Myosin Heavy Chain 9 (MYH9) Antibody – Rabbit Polyclonal
For Research Use Only. Not for use in diagnostic procedures. Special Promotion Catalog #: MBS2120228SPECIAL PROMOTION: Get FREE Starbucks gift card (Maximum 5 gift cards/product). Gift card(s) will be included with shipment
MBS2120228 is an antibody targeting MYH9. Also known as APC-Linked Polyclonal Antibody to Myosin Heavy Chain 9, Non Muscle (MYH9). Reactive in Human, Pig. Host: Rabbit. More details
Product Overview
Online Datasheet in PDFProduct Name
Myosin Heavy Chain 9 (MYH9), Polyclonal Antibody
Full Product Name
APC-Linked Polyclonal Antibody to Myosin Heavy Chain 9, Non Muscle (MYH9)
Product Gene Name
anti-MYH9 antibody
Product Synonym Names
DFNA17; EPSTS; FTNS; MHA; NMHC-II-A; NMMHCA; Nonmuscle Myosin Heavy Chain II-A; Cellular myosin heavy chain, type A; Myosin heavy chain, non-muscle IIa
Immunogen Sequence
Glu1740~Gl u1960
Clonality
Polyclonal
Host
Rabbit
Species Reactivity
Human, Pig
Form/Format
Liquid; PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Purity/Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Concentration
>=100ug/ml (lot specific)
Specificity
The antibody is a rabbit polyclonal antibody raised against MYH9. It has been selected for its ability to recognize MYH9 in immunohistochemical staining and western blotting.
Preparation and Storage
Store at 4 degree C for frequent use. Aliquot and store at -20 degree C for 12 months.
Avoid repeated freeze/thaw cycles.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Avoid repeated freeze/thaw cycles.
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37 degree C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
Matching Pairs
Unconjugated Antibody: MYH9 (MBS2112304)
APC Conjugated Antibody: MYH9 (MBS2120228)
APC Conjugated Antibody: MYH9 (MBS2120228)
Matching Pairs
APC Conjugated Antibody: MYH9 (MBS2120228)
Immunogen: MYH9 (MBS2123084)
Immunogen: MYH9 (MBS2123084)
Molecular Weight
226,532 Da
OMIM
153640
Supply Chain Verification
Manufactured in a lab with traceable raw materials. Bulk orders can typically be prepared to the customer’s specifications, please inquire.
Immunogen Sequence
Glu1740~Glu1960
Cross Reactivity
Human
Conjugation
APC
Product Categories/Family for anti-MYH9 antibody
Metabolic Pathway
ISO Certification
Manufactured in an ISO 9001:2015 and ISO 13485:2016 Certified Laboratory.
Applications Tested/Suitable for anti-MYH9 antibody
Western Blot (WB), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunoprecipitation (IP)
Other Notes
Small volumes of anti-MYH9 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for MYH9. It may not necessarily be applicable to this product.
NCBI Official Full Name
myosin-9
NCBI Official Synonym Full Names
myosin, heavy chain 9, non-muscle
NCBI Official Symbol
MYH9
NCBI Official Synonym Symbols
MHA; FTNS; EPSTS; BDPLT6; DFNA17; NMMHCA; NMHC-II-A; NMMHC-IIA
UniProt Protein Name
Myosin-9
UniProt Synonym Protein Names
Cellular myosin heavy chain, type A; Myosin heavy chain 9; Myosin heavy chain, non-muscle IIa; Non-muscle myosin heavy chain A; NMMHC-A; Non-muscle myosin heavy chain IIa
Protein Family
Myosin
UniProt Gene Name
MYH9
UniProt Synonym Gene Names
NMMHC-A; NMMHC II-a; NMMHC-IIA
UniProt Entry Name
MYH9_HUMAN
NCBI Protein Information
myosin-9; myosin heavy chain 9; non-muscle myosin heavy chain A; non-muscle myosin heavy chain IIa; nonmuscle myosin heavy chain II-A; myosin heavy chain, non-muscle IIa; cellular myosin heavy chain, type A; non-muscle myosin heavy polypeptide 9
NCBI Summary for MYH9
This gene encodes a conventional non-muscle myosin; this protein should not be confused with the unconventional myosin-9a or 9b (MYO9A or MYO9B). The encoded protein is a myosin IIA heavy chain that contains an IQ domain and a myosin head-like domain which is involved in several important functions, including cytokinesis, cell motility and maintenance of cell shape. Defects in this gene have been associated with non-syndromic sensorineural deafness autosomal dominant type 17, Epstein syndrome, Alport syndrome with macrothrombocytopenia, Sebastian syndrome, Fechtner syndrome and macrothrombocytopenia with progressive sensorineural deafness. [provided by RefSeq, Dec 2011]
Show more UniProt Comments for MYH9
MYH9: Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Interacts with PDLIM2. Interacts with SLC6A4. Myosin is a hexameric protein that consists of 2 heavy chain subunits (MHC), 2 alkali light chain subunits (MLC) and 2 regulatory light chain subunits (MLC-2). Interacts with RASIP1. Interacts with DDR1. Interacts with SVIL and HTRA3. In the kidney, expressed in the glomeruli. Also expressed in leukocytes. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Motor; Motility/polarity/chemotaxis; Actin-binding
Chromosomal Location of Human Ortholog: 22q13.1
Cellular Component: cortical cytoskeleton; signalosome; protein complex; myosin II complex; leading edge; contractile ring; immunological synapse; actomyosin; cytosol; actin cytoskeleton; ruffle; cell-cell adherens junction; membrane; cytoplasm; plasma membrane; stress fiber; spindle; uropod; integrin complex; neuromuscular junction; nucleus; cleavage furrow
Molecular Function: actin filament binding; calmodulin binding; microfilament motor activity; protein binding; protein homodimerization activity; protein anchor; ATPase activity; motor activity; actin binding; ADP binding; actin-dependent ATPase activity; ATP binding
Biological Process: integrin-mediated signaling pathway; axon guidance; blood vessel endothelial cell migration; monocyte differentiation; actin filament-based movement; in utero embryonic development; actomyosin structure organization and biogenesis; membrane protein ectodomain proteolysis; cytokinesis; uropod organization and biogenesis; regulation of cell shape; establishment of meiotic spindle localization; protein transport; actin cytoskeleton reorganization; ephrin receptor signaling pathway; establishment of T cell polarity; angiogenesis; platelet formation; leukocyte migration; myoblast fusion; meiotic spindle organization and biogenesis
Disease: Deafness, Autosomal Dominant 17; May-hegglin Anomaly; Fechtner Syndrome; Macrothrombocytopenia And Progressive Sensorineural Deafness; Epstein Syndrome; Sebastian Syndrome
Show more Protein type: Motor; Motility/polarity/chemotaxis; Actin-binding
Chromosomal Location of Human Ortholog: 22q13.1
Cellular Component: cortical cytoskeleton; signalosome; protein complex; myosin II complex; leading edge; contractile ring; immunological synapse; actomyosin; cytosol; actin cytoskeleton; ruffle; cell-cell adherens junction; membrane; cytoplasm; plasma membrane; stress fiber; spindle; uropod; integrin complex; neuromuscular junction; nucleus; cleavage furrow
Molecular Function: actin filament binding; calmodulin binding; microfilament motor activity; protein binding; protein homodimerization activity; protein anchor; ATPase activity; motor activity; actin binding; ADP binding; actin-dependent ATPase activity; ATP binding
Biological Process: integrin-mediated signaling pathway; axon guidance; blood vessel endothelial cell migration; monocyte differentiation; actin filament-based movement; in utero embryonic development; actomyosin structure organization and biogenesis; membrane protein ectodomain proteolysis; cytokinesis; uropod organization and biogenesis; regulation of cell shape; establishment of meiotic spindle localization; protein transport; actin cytoskeleton reorganization; ephrin receptor signaling pathway; establishment of T cell polarity; angiogenesis; platelet formation; leukocyte migration; myoblast fusion; meiotic spindle organization and biogenesis
Disease: Deafness, Autosomal Dominant 17; May-hegglin Anomaly; Fechtner Syndrome; Macrothrombocytopenia And Progressive Sensorineural Deafness; Epstein Syndrome; Sebastian Syndrome
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with anti-MYH9 antibody
| Reference Product | PubMed Publications |
|---|---|
| MYH10 antibody | >9 publications with MYH9 and MYH10 |
| S100A4 antibody | >5 publications with MYH9 and S100A4 |
| MYH11 antibody | >4 publications with MYH9 and MYH11 |
| MYL9 antibody | >3 publications with MYH9 and MYL9 |
| MYL12A antibody | >1 publications with MYH9 and MYL12A |
| MYL12B antibody | >1 publications with MYH9 and MYL12B |
| MYL6 antibody | >1 publications with MYH9 and MYL6 |
Pathways associated with anti-MYH9 antibody
| Products by Pathway | Pathway Diagram |
|---|---|
| Axon Guidance Pathway antibodies | Axon Guidance Pathway Diagram |
| Developmental Biology Pathway antibodies | Developmental Biology Pathway Diagram |
| EPH-Ephrin Signaling Pathway antibodies | EPH-Ephrin Signaling Pathway Diagram |
| EPHA-mediated Growth Cone Collapse Pathway antibodies | EPHA-mediated Growth Cone Collapse Pathway Diagram |
| Fcgamma Receptor (FCGR) Dependent Phagocytosis Pathway antibodies | Fcgamma Receptor (FCGR) Dependent Phagocytosis Pathway Diagram |
| Immune System Pathway antibodies | Immune System Pathway Diagram |
| Innate Immune System Pathway antibodies | Innate Immune System Pathway Diagram |
| Regulation Of Actin Cytoskeleton Pathway antibodies | Regulation Of Actin Cytoskeleton Pathway Diagram |
| Regulation Of Actin Cytoskeleton Pathway antibodies | Regulation Of Actin Cytoskeleton Pathway Diagram |
| Regulation Of Actin Dynamics For Phagocytic Cup Formation Pathway antibodies | Regulation Of Actin Dynamics For Phagocytic Cup Formation Pathway Diagram |
Diseases associated with anti-MYH9 antibody
| Disease Name | Pubmed Publications |
|---|---|
| Kidney Diseases Antibodies | >131 publications with MYH9 and Kidney Diseases |
| MYH9-Related Disorders Antibodies | >53 publications with MYH9 and MYH9-Related Disorders |
| Congenital Abnormalities Antibodies | >45 publications with MYH9 and Congenital Abnormalities |
| Immune System Diseases Antibodies | >42 publications with MYH9 and Immune System Diseases |
| Glomerulosclerosis, Focal Segmental Antibodies | >37 publications with MYH9 and Glomerulosclerosis, Focal Segmental |
| Cardiovascular Diseases Antibodies | >36 publications with MYH9 and Cardiovascular Diseases |
| Kidney Failure, Chronic Antibodies | >34 publications with MYH9 and Kidney Failure, Chronic |
| Proteinuria Antibodies | >31 publications with MYH9 and Proteinuria |
| Nephritis, Hereditary Antibodies | >29 publications with MYH9 and Nephritis, Hereditary |
| Neoplasms Antibodies | >26 publications with MYH9 and Neoplasms |
Organs/Tissues associated with anti-MYH9 antibody
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >171 publications with MYH9 and Blood |
| Kidney Antibodies | >122 publications with MYH9 and Kidney |
| Muscle Antibodies | >103 publications with MYH9 and Muscle |
| Bone Antibodies | >22 publications with MYH9 and Bone |
| Vascular Antibodies | >19 publications with MYH9 and Vascular |
| Heart Antibodies | >18 publications with MYH9 and Heart |
| Lung Antibodies | >17 publications with MYH9 and Lung |
| Bone Marrow Antibodies | >17 publications with MYH9 and Bone Marrow |
| Ear Antibodies | >12 publications with MYH9 and Ear |
| Brain Antibodies | >11 publications with MYH9 and Brain |


